Se espera que el tamaño del mercado de tratamiento de infecciones del tracto respiratorio alcance los 69,13 mil millones de dólares para 2031 desde los 43,6 mil millones de dólares en 2023; se prevé que registre una tasa compuesta anual del 5,93 % durante 2023-2031.
Las infecciones del tracto respiratorio, o ITR, son infecciones de los senos nasales, la garganta, las vías respiratorias o los pulmones. El informe sobre el mercado global de tratamiento de infecciones del tracto respiratorio enfatiza los factores clave que impulsan el mercado y describe los desarrollos de los actores destacados. Los factores clave que impulsan el crecimiento del mercado incluyen la creciente prevalencia de infecciones respiratorias a nivel mundial, una mayor concienciación sobre las infecciones del tracto respiratorio y diversas terapias relacionadas con las infecciones del tracto respiratorio, y un número cada vez mayor de ensayos clínicos relacionados con el tratamiento de las infecciones del tracto respiratorio. . Sin embargo, la falta de investigación centrada en la terapéutica respiratoria y los efectos adversos relacionados con los medicamentos para las infecciones respiratorias obstaculiza el crecimiento del mercado. Además, se espera que la llegada del tratamiento antiviral traiga nuevas tendencias globales del mercado de tratamiento de infecciones del tracto respiratorio en los próximos años.
Impulsores y restricciones del crecimiento:
Demanda creciente de diagnóstico de enfermedades respiratorias entre la población de edad avanzada
El análisis del mercado global de tratamiento de infecciones del tracto respiratorio se ha llevado a cabo considerando los siguientes segmentos: indicación de enfermedad farmacológica, vía de administración, grupo de edad y canal de distribución. Según los medicamentos, el mercado se diferencia en antibióticos, AINE, antitusígenos, descongestionantes nasales y otros. Por indicación de enfermedad, el mercado mundial de tratamiento de infecciones del tracto respiratorio se segmenta en infección del tracto respiratorio superior e infección del tracto respiratorio inferior. En cuanto a la vía de administración, el mercado se diferencia en oral y parenteral. Según el grupo de edad, el mercado se clasifica en pediátrico y adulto. Según el canal de distribución, el mercado mundial de tratamiento de infecciones del tracto respiratorio se segmenta en farmacias hospitalarias, farmacias en línea y farmacias minoristas.
Análisis segmentario:
En términos de medicamentos, el segmento de antibióticos tuvo la mayor cuota de mercado mundial de tratamiento de infecciones del tracto respiratorio en 2023. El segmento Se prevé que registre la CAGR más alta durante 2023-2031. Las infecciones del tracto respiratorio abarcan una variedad de dolencias, que incluyen bronquitis, neumonía y sinusitis, a menudo causadas por patógenos bacterianos. Los antibióticos atacan y eliminan estas bacterias dañinas, reduciendo la inflamación y promoviendo una recuperación más rápida. Los antibióticos comúnmente recetados para las infecciones del tracto respiratorio incluyen penicilinas, cefalosporinas, macrólidos, fluoroquinolonas y tetraciclinas, y cada uno de ellos tiene mecanismos de acción y objetivos bacterianos únicos.
Según la indicación de la enfermedad, El segmento de infecciones del tracto respiratorio inferior tuvo una mayor participación de mercado en 2023. Además, se prevé que registre una CAGR más alta de 2023 a 2031. Las infecciones del tracto respiratorio inferior (LRTI) son infecciones que afectan los pulmones y los bronquios, generalmente causadas por bacterias, patógenos virales o fúngicos, entre otros. Condiciones como neumonía, bronquitis y bronquiolitis, que típicamente presentan síntomas como tos productiva, malestar en el pecho, dificultad para respirar y fiebre, se clasifican en el espectro de LRTI. La neumonía, una IVRI grave, implica inflamación e infección del tejido pulmonar, lo que provoca consolidación pulmonar (algunas áreas del pulmón o el órgano completo) y alteración del intercambio de gases.
Por vía de administración, el segmento oral tuvo una mayor participación en el mercado mundial de tratamiento de infecciones del tracto respiratorio; Se prevé que el segmento registre una CAGR más alta durante 2023-2031. Con frecuencia se recetan antibióticos orales como amoxicilina, azitromicina o doxiciclina para combatir los patógenos bacterianos que causan infecciones del tracto respiratorio. Además de los antibióticos, los corticosteroides orales pueden reducir la inflamación en el asma grave o en las exacerbaciones del trastorno pulmonar obstructivo crónico (EPOC). Los medicamentos antivirales orales como el oseltamivir se utilizan para tratar infecciones respiratorias virales como la influenza. Las ventajas comunes de la vía oral incluyen una fácil administración, el cumplimiento del paciente y la distribución sistémica del fármaco.
En términos de grupo de edad, el segmento de adultos tenía una mayor proporción del mercado global de tratamiento de infecciones del tracto respiratorio en 2023. Se prevé que el segmento de pediatría registre una CAGR más alta durante 2023-2031. Factores como la conciencia relacionada con la importancia del diagnóstico y tratamiento tempranos de las infecciones respiratorias en niños y los avances en los dispositivos respiratorios utilizados para el tratamiento están conduciendo al desarrollo de opciones de tratamiento nuevas y más efectivas. Además, el creciente enfoque en la atención médica preventiva está contribuyendo al crecimiento del mercado para el segmento pediátrico.
En términos de canal de distribución, se prevé que el segmento de farmacias hospitalarias represente una cuota de mercado significativa durante 2023-2031. Las farmacias hospitalarias sirven como componentes clave de un sistema de salud; En particular, desempeñan un papel vital en el tratamiento de infecciones agudas y graves del tracto respiratorio, que requieren la administración de medicamentos por vía intravenosa o intramuscular. Estas farmacias son responsables de obtener, almacenar y dispensar antibióticos, antivirales, corticosteroides y otros tratamientos para infecciones respiratorias, además de garantizar su entrega segura y oportuna a pacientes hospitalizados y ambulatorios.
Análisis Regional:
La creciente concientización entre la población sobre la importancia del diagnóstico y tratamiento temprano de Es probable que las infecciones respiratorias contribuyan al crecimiento del mercado mundial del tratamiento de infecciones del tracto respiratorio en los próximos años. El mercado está segmentado en América del Norte, Europa, Asia-Pacífico, Medio Oriente y África, y América del Sur y Central. América del Norte tuvo la mayor cuota de mercado mundial de tratamiento de infecciones del tracto respiratorio en 2023. El mercado en América del Norte está experimentando un crecimiento significativo debido a la elevada prevalencia de infecciones del tracto respiratorio en el país. Factores como la contaminación del aire, el tabaquismo y las condiciones de vida hacinadas contribuyen a la alta incidencia de infecciones respiratorias en el país. El aumento de la prevalencia de infecciones respiratorias, un aumento de la conciencia sobre la atención sanitaria y las iniciativas favorables del gobierno están impulsando el crecimiento del mercado mundial de tratamiento de infecciones del tracto respiratorio.
< u>Panorama competitivo y empresas clave:
El sector respiratorio global El pronóstico del mercado de tratamiento de infecciones del tracto puede ayudar a las partes interesadas a planificar sus estrategias de crecimiento. Abbott Laboratories, AstraZeneca plc, Alembic Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche AG, Sanofi SA, Merck & Co., Cipla se encuentran entre los actores destacados perfilados en el informe del mercado global de tratamiento de infecciones del tracto respiratorio. Estas empresas se centran en diversas estrategias (tanto orgánicas como inorgánicas) para satisfacer la creciente demanda de los consumidores y ampliar su gama de productos en carteras especializadas. Las principales estrategias adoptadas por las empresas en el mercado incluyen lanzamientos de nuevas tecnologías, desarrollos de productos existentes y expansiones geográficas.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Based on drug, the market is segmented into Antibiotics, NSAIDs, Cough Suppressants, Nasal Decongestants, and Others. The antibiotics segment held the largest respiratory tract infection treatment market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.
Based on disease indication, the respiratory tract infection treatment market is segmented into LRTI and URTI. The LRTI is anticipated to hold a significant share by 2031.
The respiratory tract infection treatment market was valued at US$ 43.60 billion in 2023.
The respiratory tract infection treatment market is expected to be valued at US$ 69.13 billion in 2031.
The respiratory tract infection treatment market has major market players, including Abbott Laboratories, AstraZeneca plc, Alembic Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche AG, Sanofi S.A., Merck & Co and Cipla.
The key factors driving the respiratory tract infection treatment market growth are the demand for the diagnosis of respiratory diseases owing to the rising prevalence of these diseases coupled with rising demand for OTC products. In addition, continuous research and development in this field has resulted in various diagnostic tests and procedures that will positively affect the growth of the market in the coming years.
Respiratory diseases such as asthma, bronchitis, allergic rhinitis, pneumonia and sinusitis can seriously impair a person's physical functioning. Symptoms associated with both mild and severe diseases of these respiratory tracts include cough, wheezing, chest pain, difficulty breathing, and shortness of breath, congestion and, in severe cases, even death. These conditions cause significant morbidity and high costs to society. Treatment of the above respiratory disease is known as respiratory tract infection treatment.
The List of Companies - Respiratory Tract Infection Market
- Merck & Co
- Abbott
- AbbVie
- Sanofi
- GlaxoSmithKline plc
- F. Hoffmann La Roche Ltd.
- Pfizer, Inc.
- Novartis AG
- Teva Pharmaceuticals
- Boehringer Ingelheim GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)